Literature DB >> 11911190

Oral delivery of antigens in liposomes with some lipid compositions modulates oral tolerance to the antigens.

Kazuyoshi Masuda1, Kazutoshi Horie, Ryuji Suzuki, Takayoshi Yoshikawa, Koichiro Hirano.   

Abstract

Several liposomes containing ovalbumin (OVA), a model antigen, with different lipid compositions were prepared in order to evaluate their ability to induce oral tolerance. Oral administration of these liposomal OVAs induced suppression of the proliferative responses of popliteal lymph node cells from the treated mice to OVA, suggesting that these treated mice were tolerized. The efficiency of the induction of oral tolerance was affected by the liposome composition. OVA entrapment in these liposomes could modulate the tolerizing dose of OVA itself. These results suggest that some liposomes can be suitable antigen-delivery systems for modulated and/or effective induction of oral tolerance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11911190     DOI: 10.1111/j.1348-0421.2002.tb02677.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  4 in total

Review 1.  From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.

Authors:  Natalie L Trevaskis; Lisa M Kaminskas; Christopher J H Porter
Journal:  Nat Rev Drug Discov       Date:  2015-10-16       Impact factor: 84.694

Review 2.  Phospholipids and lipid-based formulations in oral drug delivery.

Authors:  Gert Fricker; Torsten Kromp; Armin Wendel; Alfred Blume; Jürgen Zirkel; Herbert Rebmann; Constanze Setzer; Ralf-Olaf Quinkert; Frank Martin; Christel Müller-Goymann
Journal:  Pharm Res       Date:  2010-04-22       Impact factor: 4.200

Review 3.  Oral tolerance as antigen-specific immunotherapy.

Authors:  Natália Pinheiro-Rosa; Lícia Torres; Mariana de Almeida Oliveira; Marcos Felipe Andrade-Oliveira; Mauro Andrade de Freitas Guimarães; Monique Macedo Coelho; Juliana de Lima Alves; Tatiani Uceli Maioli; Ana M Caetano Faria
Journal:  Immunother Adv       Date:  2021-08-25

4.  IL-28 supplants requirement for T(reg) cells in protein sigma1-mediated protection against murine experimental autoimmune encephalomyelitis (EAE).

Authors:  Agnieszka Rynda; Massimo Maddaloni; Javier Ochoa-Repáraz; Gayle Callis; David W Pascual
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.